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Abstract Oxidative stress-induced tyrosine phosphorylation 
has been ascribed to activation of phosphotyrosine kinase or to 
inhibition of phosphotyrosine phosphatase (PTP). We have 
previously identified a PTP associated with band 3 in the human 
erythrocyte membrane, a PTP that is normally highly active and 
prevents the appearance of band 3 phosphotyrosine. Here we 
show that treatment of erythrocytes with the thiol-oxidizing 
agent diamide leads to the formation of PTP disulfides (PTP-
band 3 mixed disulfides) and inhibition of dephosphorylation, 
allowing the accumulation of band 3 phosphotyrosine. Upon 
reduction of the disulfides, the band 3 phosphotyrosine is 
dephosphorylated. Erythrocyte thiol alkylation by Af-ethylmalei-
mide results in irreversible PTP inhibition and irreversible 
phosphorylation. The results are consistent with the notion that 
alterations in cellular thiol status affect the cell phosphotyrosine 
status and that oxidative stress-induced tyrosine phosphorylation 
involves inhibition of PTP. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Phosphorylation of protein tyrosine residues plays an essen-
tial role in the regulation of diverse cellular functions. The 
level of any particular protein phosphotyrosine is controlled 
by members of two opposing enzyme families, phosphotyro-
sine kinases (PTKs) and phosphotyrosine phosphatases 
(PTPs), acting at that specific protein site [1-3]. Normally, 
the activity of PTP is very high relative to that of PTK, so 
that a very low basal level of phosphotyrosine is maintained 
in the cell [1-3]. Tyrosine phosphorylation of receptors and of 
certain cellular proteins is promoted by the binding of ligands 
(e.g. E G F , insulin) to their receptors [4,5]. Protein tyrosine 
phosphorylation in the intact cell can also be promoted by 
a variety of agents, notably agents which affect the system via 
oxidative stress [5-16]. These include hydrogen peroxide (usu-
ally added to the cells together with the P T P inhibitor vana-
date, or generated within the cell) [5,8-13], the thiol oxidizing 
agent diamide [6-8], thiol alkylating agents [11,13], nitric ox-
ide [14,15], as well as UV irradiation [13]. In some cases, the 
enhanced tyrosine phosphorylation was suggested to result 
from direct oxidation and activation of P T K [7,10,12]. How-
ever, since all PTPs contain at their active center a highly 
reactive cysteine residue that is essential for phosphatase ac-
tivity [1,17], inhibitory effects of the oxidants on P T P activity 
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have been considered to be the more likely mechanism, indi-
rectly responsible for the tyrosine phosphorylation observed 
[5,11-16]. The PTPs involved and the alterations induced by 
the agents in the PTPs and in the substrates have not been 
identified. 
We have previously identified a P T P associated with band 3 
in the human erythrocyte membrane [18]. The PTP seems to 
be related to PTP IB (identified using an antibody to an epit-
ope in its catalytic domain and by molecular mass), with the 
major fraction tightly bound to the cell membrane, along with 
the major part of band 3. The system described allows the 
study of the interaction of a PTP with a known, endogenous 
substrate under normal conditions and the identification of 
agent-induced alterations in the system. We show here that 
alterations in erythrocyte thiol status lead to alterations in 
PTP and result in band 3 tyrosine phosphorylation. Treat-
ment with the thiol-oxidizing agent diamide [19] leads to the 
formation of PTP disulfides (which appear to be mixed disul-
fides involving band 3) and results in inhibition of P T P activ-
ity and in band 3 tyrosine phosphorylation. Both the disulfide 
formation and the phosphorylation are reversible. Irreversible 
erythrocyte thiol alkylation by JV-ethylmaleimide (NEM) re-
sults in irreversible P T P inhibition and irreversible phospho-
rylation. The results are consistent with the notion that alter-
ations in cellular thiol status may, as part of the perturbations 
in cellular functions, affect the cell phosphotyrosine status. 
2. Materials and methods 
2.1. Thiol modification of erythrocytes 
Blood (obtained from healthy humans using EDTA as an antico-
agulant) was centrifuged, plasma and buffy coat removed and the 
erythrocytes washed three times with 150 mM NaCl. Erythrocytes 
were suspended to 10% hematocrit in 25 mM HEPES buffer, pH 
7.3/125 mM NaCl and incubated for 30 min at 37°C in the presence 
or absence of 1.0 mM diamide [19] or 2.0 mM NEM. Aliquots of the 
treated erythrocytes were washed and reincubated for 30 min in buffer 
containing 5.0 mM dithiothreitol (DTT). 
2.2. Erythrocyte membranes and membrane extracts 
Erythrocyte membranes were prepared by hemolyzing the cells in 
5 mM sodium phosphate buffer, pH 8.0, containing 1.0 mM EDTA 
and 0.1 mM phenylmethylsulfonyl fluoride (PMSF). Membranes were 
washed with the same buffer, then further washed with 10 mM NaCl/ 
0.1 mM PMSF to obtain hemoglobin-free membranes. For the iden-
tification of the membrane proteins, aliquots were solubilized and 
boiled in Laemmli's SDS sample buffer under nonreducing and reduc-
ing conditions (i.e. in the absence and presence of 10 mM DTT), 
resolved by 10% SDS/PAGE and stained by Coomassie blue. Mem-
brane extracts were prepared by suspending membranes in cold 25 
mM HEPES buffer, pH 7.3, containing 1.0 mM DTT, 0.1 mM 
PMSF and 0.2% Triton X-100 (HEPES/Triton), as previously de-
scribed [18]. The Triton-treated membrane suspensions were kept on 
ice for 30 min, then centrifuged at 40000Xg. The supernatants were 
used as the membrane extracts. 
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2.3. Analysis of phosphotyrosine, of band 3 and of PTP by 
immunoblotting 
Proteins of the solubilized membranes and extracts were resolved by 
10% SDS/PAGE, followed by transfer to nitrocellulose membranes 
and immunoblotting analysis, as previously described [18]. For the 
analysis of phosphotyrosine, the nitrocellulose membranes were 
blocked for 15 h at room temperature in a solution of 50 mM Tris, 
pH 7.4/150 mM NaCl/0.1% Tween-20 (TNT), containing 3.0% bovine 
serum albumin (BSA) and 0.05% NaN3, then incubated for additional 
2 h at room temperature with monoclonal anti-phosphotyrosine anti-
body (BioMakor, Rehovot, Israel; antibody diluted 1:2000). After 
washing with the blocking solution (without NaN3), the membranes 
were incubated for 1 hr with goat anti-mouse peroxidase-conjugated 
antibodies (Amersham), washed in TNT and analyzed, using the ECL 
detection system (Amersham). Similar procedure was carried out for 
band 3 immunoblotting, using monoclonal anti-band 3 antibody (Bio-
Makor; antibody diluted 1:20000). For the immunoblot analysis of 
PTP, the nitrocellulose membranes were processed as described above 
for anti-phosphotyrosine immunoblotting, but with 0.3% gelatin in 
the blocking solution instead of BSA, using monoclonal anti-PTPlB 
antibody FG6-1G (Oncogene Science) at a concentration of 2 itg/ml 
[18]. 
3. Results 
3.1. Tyrosine phosphorylation in diamide-treated erythrocytes 
Erythrocytes were incubated in the presence and absence of 
diamide, membranes prepared, solubilized in nonreducing and 
reducing sample buffer and analyzed by SDS-PAGE and by 
immunoblotting for phosphotyrosine. Coomassie blue stain-
ing of membrane proteins obtained from diamide-treated er-
ythrocytes and electrophoresed under nonreducing conditions 
showed high molecular weight (HMW) fractions at the origin 
of the gel (Fig. 1, lane 1). Phosphotyrosine was observed in 
the diamide-treated erythrocytes, in the band corresponding 
to band 3 protein and in the HMW bands (Fig. 1, lane 4). 
When diamide-treated cells were reincubated with DTT, the 
HMW fractions were reduced and the protein profile reverted 
to the original, control protein profile (Fig. 1, lane 2). The 
diamide-treated erythrocytes which were reincubated with 
DTT did not show any tyrosine phosphorylation (Fig. 1, 
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Fig. 1. Tyrosine phosphorylation in diamide-treated erythrocytes. 
Erythrocyte suspensions (10%) were incubated for 30 min at 37°C 
in the presence and absence of 1.0 mM diamide. One part was then 
washed and incubated with 5.0 mM DTT for 30 min. Membranes 
were prepared, solubilized in sample buffer in the absence or pres-
ence of DTT and analyzed by SDS-PAGE and phosphotyrosine im-
munoblotting, as described in Section 2. Lanes 1 and 4, membranes 
of diamide-treated erythrocytes solubilized in the absence of DTT; 
lanes 2 and 3, diamide-treated erythrocytes reincubated with DTT; 
lane 5, membranes of diamide-treated erythrocytes solubilized in the 
presence of DTT; lane 6, control erythrocytes. 
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Fig. 2. Band 3 and PTP in diamide-treated erythrocytes. Experimen-
tal conditions were the same as in Fig. 1. Membranes were solubi-
lized in sample buffer in the absence of DTT and analyzed for band 
3 and PTP by immunoblotting, as described in Section 2. Lanes 1 
and 4, control erythrocytes; lanes 2 and 5, diamide-treated erythro-
cytes; lanes 3 and 6, diamide-treated erythrocytes incubated with 
DTT, then solubilized. 
lane 3). When membranes isolated from diamide-treated er-
ythrocytes were solubilized in sample buffer containing DTT, 
the HMW phosphorylated fractions diminished significantly, 
with band 3 remaining strongly phosphorylated (Fig. 1, lane 
5). No phosphotyrosine was observed in erythrocytes incu-
bated in the absence of diamide (Fig. 1, lane 6). Thus, oxida-
tion of erythrocyte thiols resulted in band 3 tyrosine phos-
phorylation, which was reversible upon reduction of the 
disulfides in the intact cells by DTT. 
3.2. Band 3 and PTP oxidation in diamide-treated erythrocytes 
Erythrocytes were treated as described above, membranes 
solubilized and analyzed by immunoblotting for band 3 and 
PTP. In the control cells, band 3 appeared as approximately 
95 kDa band (Fig. 2, lane 1). Part of band 3 was oxidized to 
HMW fractions in diamide-treated cells (Fig. 2, lane 2) and 
was reduced back to the 95 kDa band in erythrocytes reincu-
bated with DTT after the diamide treatment (Fig. 2, lane 3). 
PTP, which appeared as a 50 kDa band in the control eryth-
rocytes (Fig. 2, lane 4), was oxidized to HMW fractions (Fig. 
2, lane 5) and was reduced back to the 50 kDa band in cells 
reincubated with DTT after diamide (Fig. 2, lane 6). The 
position of the oxidized PTP appeared to be similar to that 
of the oxidized band 3 (Fig. 2, lanes 2 and 5). 
A two-dimensional SDS-PAGE and immunoblotting 
showed that the oxidized PTP and band 3, present in the 
same HMW fraction in the non-reduced gels, were resolved 
on the second dimension reducing gel, to PTP and band 3 
(data not shown). 
3.3. Autodephosphorylation of erythrocyte membranes 
We previously found that following erythrocyte band 3 ty-
rosine phosphorylation in erythrocyte membranes in the pres-
ence of vanadate, dephosphorylation of band 3 was achieved 
by removing the vanadate and incubating the membranes with 
Mg2+ and DTT [18]. In order to examine whether the pres-
ence of band 3 phosphotyrosine in the oxidized cells was due 
to inhibition of PTP, membranes were isolated from diamide-
treated erythrocytes and incubated with Mg2+, in the presence 
of either diamide (to ensure that the membranes remained in 
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Fig. 3. Phosphotyrosine dephosphorylation in erythrocyte mem-
branes. Membranes were prepared from diamide-treated erythro-
cytes and suspended at 1.0 mg protein/ml in HEPES/PMSF buffer 
containing 10 mM Mg2+. Membrane suspensions were incubated 
for 30 min at 37°C in the presence of either 0.5 mM diamide or 5.0 
mM DTT, solubilized and analyzed for phosphotyrosine and for 
PTP. Lanes 1 and 4, unincubated membranes; lanes 2 and 5, mem-
branes incubated with diamide; lanes 3 and 6, membranes incubated 
with DTT. 
the oxidized state) or DTT. When the membranes, isolated 
from the oxidized cells, were incubated in the presence of 
diamide, very little, if any, band 3 dephosphorylation oc-
curred, with the phosphorylated HMW fractions remaining 
(Fig. 3, lanes 1 and 2). Under these conditions, PTP was 
present in the HMW fractions, including those at the origin 
of the stacking gel and at the origin of the separating gel (Fig. 
3, lanes 4 and 5). In the presence of DTT, the HMW phos-
phorylated fractions disappeared and band 3 protein under-
went dephosphorylation (Fig. 3, lane 3). Immunoblotting for 
PTP showed that in the presence of DTT, PTP disappeared 
from the HMW fractions and reappeared as a 50 kDa fraction 
(Fig. 3, lane 6). The results indicate that PTP thiol oxidation 
causes inhibition of phosphotyrosine dephosphorylation and 
that such an inhibition can be reversed and dephosphorylation 
achieved by reduction of the diamide-induced disulfides. 
3.4. Effects of NEM on band 3 tyrosine phosphorylation 
Erythrocytes were treated with NEM, washed and reincu-
bated with DTT. Band 3 phosphotyrosine was found in eryth-
rocytes incubated with NEM (Fig. 4, lane 1). No dephospho-
rylation was observed in the erythrocytes reincubated with 
DTT (Fig. 4, lane 2). Membranes which were prepared from 
NEM-treated erythrocytes and incubated with Mg2+ and 
DTT did not show any dephosphorylation (Fig. 4, lane 3). 
In contrast, band 3 dephosphorylation did occur in mem-
branes which were prepared from vanadate-treated cells and 
incubated in the absence of vanadate (Fig. 4, lanes 4 and 5). 
The results indicate that, whereas vanadate-induced PTP in-
hibition and band 3 tyrosine phosphorylation is reversible, the 
phosphorylation following the irreversible thiol alkylation by 
NEM is not reversible. Immunoblot analysis of PTP from 
NEM-treated erythrocytes showed the same 50 kDa band as 
the control PTP (not shown). 
3.5. Effects of band 3 thiol alterations on dephosphorylation of 
band 3 phosphotyrosine 
We previously found that Triton X-100 extracts of eryth-
rocyte membranes contain band 3 and associated PTP, and 
that band 3 dephosphorylation can be achieved in the Triton-
extracts of phosphorylated membranes by the addition of 
Mg2+ and DTT [18]. In order to find out whether thiol-altered 
band 3 is a substrate for PTP, we carried out the following 
experiment. Membranes isolated from control and from 
NEM-treated erythrocytes were extracted with Triton X-100. 
Extracts of the alkylated samples were mixed with extracts of 
control samples (Fig. 5, lanes 1 and 2), or with extract buffer 
alone (Fig. 5, lanes 3 and 4). Aliquots of the mixtures were 
kept in ice (Fig. 5, lanes 1 and 3) or incubated in the presence 
of Mg2+ and DTT (Fig. 5, lanes 2 and 4) and phosphotyro-
sine analyzed by immunoblotting. Incubation of the alkylated 
sample that was mixed with control extract led to dephos-
phorylation of the phosphotyrosine in the thiol-altered band 
3 (Fig. 5, lane 2 versus lane 1). In contrast, no dephospho-
rylation was observed in the sample lacking the control ex-
tract (Fig. 5, lane 4 versus lane 3). These results indicate that 
thiol-altered band 3 is accessible to PTP (the suitability of 
diamide-oxidized band 3 as a substrate for PTP cannot be 
ascertained under these experimental conditions, since the di-
sulfides are reduced by the added DTT). 
4. Discussion 
Perturbation in the cellular and membrane thiol status may 
occur as a result of certain physiological processes or patho-
logical conditions and can be achieved by the use of oxidizing 
and alkylating agents [20]. Alterations in the redox status may 
be of importance in the regulation of cell protein tyrosine 
phosphorylation. The promotion of tyrosine phosphorylation 
by physiological or agent-induced oxidative stress, shown to 
occur in a variety of systems, has been ascribed to activation 
of PTK or to inhibition of PTP. The diamide-induced auto-
phosphorylation of the endoplasmic reticulum tyrosine kinase 
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Fig. 4. Effects of NEM on band 3 phosphotyrosine as compared to 
the effects of vanadate. Erythrocyte suspensions were incubated for 
30 min at 37°C with 2.0 mM NEM and washed. An aliquot of the 
NEM-treated cells was then incubated with 5.0 mM DTT for 30 
min. Other erythrocyte suspensions were incubated with 0.1 mM so-
dium orthovanadate (vanadate), as previously described [18]. Mem-
branes, prepared from NEM or from vanadate-treated erythrocytes, 
were suspended in HEPES/PMSF buffer containing 10 mM Mg2+ 
and 1.0 mM DTT, incubated for 30 min at 37°C, solubilized and 
analyzed for phosphotyrosine. Lane 1, NEM-treated erythrocytes; 
lane 2, NEM-treated erythrocytes incubated with DTT; lane 3, 
membranes (prepared from NEM-treated erythrocytes) incubated 
with Mg2+ and DTT. Lane 4, vanadate-treated erythrocytes; lane 5, 
membranes (prepared from vanadate-treated erythrocytes) incubated 
with Mg2+ and DTT. 
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Fig. 5. Band 3 dephosphorylation in membrane extracts. Triton ex-
tracts were prepared from membranes of NEM-treated erythrocytes 
and from control membranes, as described in Section 2. Extract pre-
pared from the NEM-treated erythrocytes was mixed with control 
extract or with extract buffer (one volume of control extract or ex-
tract buffer was added to one volume of extract of NEM-treated 
cells). Aliquots were incubated for 30 min at 37°C in HEPES/PMSF 
buffer containing 10 mM Mg2+ and 1.0 mM DTT. Unincubated 
and incubated aliquots were solubilized and analyzed for phospho-
tyrosine. Lanes 1 and 2, extract of NEM-treated cells mixed with 
control extract; lanes 3 and 4, extract of NEM-treated cells mixed 
with extract buffer; lanes 1 and 3, unincubated samples; lanes 2 
and 4, incubated samples. 
of the kinase [7]. However, based on the finding of an endo-
plasmic reticulum-associated PTP1B, it was subsequently pro-
posed (but not proved) that the diamide-induced activation of 
Ltk might be explained by oxidation and inhibition of PTP 
[21]. The insulinomimetic agents F^CVvanadate have been 
shown to augment the autophosphorylation of the insulin 
receptor kinase and its cellular target proteins, concomitant 
with inhibition of PTP activity in the cytosolic fraction pre-
pared from the treated cells [5,22]. Diamide has been shown to 
inhibit PTP activity in fibroblast cytoplasm without altering 
the kinase activity associated with the EGF receptor [6]. The 
H202-induced phosphorylation of EGF receptor was consid-
ered to be due to activation of a tyrosine kinase [12]. How-
ever, since dephosphorylation of receptor tyrosine kinases was 
shown to be inhibited by oxidative stress-inducing agents 
[23], it has been proposed that the phosphorylation of the 
receptors promoted by these agents is due to inhibition of 
PTP [23]. 
The studies quoted above indicate that oxidative stress-in-
duced tyrosine phosphorylation of certain receptors and sub-
strates may be due not to direct effect on PTK but to loss of 
PTP activity. The data presented here provide direct evidence 
for PTP being a target for oxidative stress and for a role of 
the thiol-altered PTP in promoting protein tyrosine phospho-
rylation. We have previously shown that treatment of erythro-
cytes with the thiol oxidizing agent diamide leads to the for-
mation of disulfide-linked, HMW membrane protein fractions 
that include some band 3 disulfides [24]. Of the five cysteine 
residues in human band 3, the two present in the N-terminal 
cytoplasmic domain (residues 201 and 317) are considered to 
be reactive and susceptible to oxidation and alkylation [25,26]. 
Here we show that diamide induces the oxidation of PTP, in 
addition to oxidation of some of the band 3 protein. Based on 
the molecular masses of the oxidized fractions and on the 
presence of both PTP and band 3 in the same HMW frac-
tions, i.e. fractions which are reduced to PTP and band 3 
upon treatment by DTT, it appears that the PTP forms mixed 
disulfides with oxidized band 3 (HMW band 3 that is com-
posed of two or more monomers). The formation of mixed 
disulfides is consistent with the association we found previ-
ously between PTP and band 3 [18]. The formation of mixed 
disulfides between proteins and small thiols (e.g. glutathione) 
is considered to be an early cellular response to oxidative 
stress [27]. The presence of mixed disulfides between associ-
ated proteins such as band 3 and PTP would indicate that in 
addition to the protein-small thiol mixed disulfides, protein-
protein mixed disulfides may be formed in response to oxida-
tive stress. Such alterations may directly affect the function of 
the associated proteins. 
We show here that the diamide-induced band 3 phospho-
rylation is reversed upon the reduction of the disulfides in the 
intact cells and that band 3 dephosphorylation in membranes 
isolated from the diamide-treated cells does not occur unless 
the disulfides are reduced back to thiols. These results indicate 
that the oxidation-induced phosphorylation is due to inhibi-
tion of PTP. The fact that the dephosphorylation of band 3 in 
NEM-treated erythrocytes or in membranes isolated from 
such cells is irreversibly inhibited, whereas the alkylated 
band 3 is a substrate for native PTP, lends further support 
to the conclusion that thiol-alteration and inhibition of PTP is 
responsible for the appearance of phosphorylated band 3. 
Since PTPs are important for the control of cell protein 
phosphotyrosine level, the regulation of PTP activity is in 
turn important for the prevention of uncontrollable dephos-
phorylation. Modulation of cellular thiol status would provide 
one of the means for modulation of PTP activity, with target 
specificity possible for both PTP activity and inhibition, via an 
association of an active PTP with the substrate and inhibition 
via the formation of PTP-substrate mixed disulfides. 
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